Comparable antileukemia/lymphoma effects in nonremission patients undergoing allogeneic hematopoietic cell transplantation with a conventional cytoreductive or reduced-intensity regimen.

Source:http://linkedlifedata.com/resource/pubmed/id/17640597

Download in:

View as

General Info

PMID
17640597